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Abstract Postmortem redistribution (PMR) is one of numer-
ous problems in postmortem toxicology making correct inter-
pretation of measured drug concentrations difficult or even
impossible. Time-dependent PMR in peripheral blood and
especially in tissue samples is still under-explored. For further
investigation, an easy applicable method for the simultaneous
quantitation of over 80 forensically relevant compounds in 11
different postmortem matrices should be developed and vali-
dated overcoming the challenges of high inter-matrix and
intra-matrix concentration variances. Biopsy samples
(20 mg) or body fluids (20 μL) were spiked with an analyte
mix and deuterated internal standards, extracted by liquid-
liquid extraction, and analyzed by liquid chromatography tan-
dem mass spectrometry (LC-MS/MS). For highest applicabil-
ity, an easy solvent calibration was used. Furthermore, time-
consuming dilution of high concentration samples showing
detector saturation was circumvented by two overlapping cal-
ibration curves using 12C isotope monitoring for low concen-
trations and 13C isotopes for high concentration, respectively.
The method was validated according to international guide-
lines with modifications. Matrix effects and extraction effi-
ciency were strongly matrix and analyte dependent. In gener-
al, brain and adipose tissue produced the highest matrix ef-
fects, whereas cerebrospinal fluid showed the least matrix
effects. Accuracy and precision results were rather matrix in-
dependent with some exceptions. Despite using an external
solvent calibration, the accuracy requirements were fulfilled
for 66 to 81 % of the 83 analytes. Depending on the matrix,
75–93 % of the analytes showed intra-day precisions at
<20 %. 12C and 13C calibrations gave comparable results
and proved to be a useful tool in expanding the dynamic
range.
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Introduction
Postmortem redistribution (PMR) is a well-recognized phe-
nomenon in forensic toxicology, which can complicate inter-
pretation of drug concentrations and conclusions on the cause
of death in medico-legal investigations. The PMR phenome-
non combines concentration changes after death due to deg-
radation, neo-formation, or diffusion processes (e.g., from
high drug concentrations in the gastrointestinal tract or the
lungs) and seems to be strongly dependent on analyte charac-
teristics and the individual case circumstances such as the
distribution of the analyte at time of death [1]. Furthermore,
the time between death and sampling time point should be of
major importance. Blood from peripheral sites—usually ob-
tained from the femoral vein—is mostly agreed to be the ma-
trix of choice for quantitation of xenobiotics because of its
distance from central organs and the gastrointestinal tract
[2]. However, even peripheral blood was shown to exhibit
massive time-dependent PMR with drug concentrations de-
creasing or increasing up to 300 % [3]. Extensive blood
clotting, collapse of the veins, putrefaction processes, or ex-
sanguination can lead to unavailability of blood for analysis. If
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no blood at all is available, alternative matrices such as liver,
kidney, muscle, lung, etc., have to be considered for toxico-
logical analysis [4]. However, the interpretation of quantita-
tion results in alternative postmortem matrices provides even
more pitfalls due to lacking reference values or unpredictable
PMR processes. PMR within solid tissues can only be as-
sumed based on site-dependent concentration differences in
samples taken at autopsy. Nevertheless, information about
time-dependent redistribution in solid tissues is needed as
these matrices are used for forensic investigations.
Collection of solid tissue samples at more than one time point
is only possible in the time window between admission of the
body at the mortuary and autopsy with biopsy sampling before
autopsy representing the only practicable strategy.
Quantitation in biopsies is not a common practice in forensic
toxicology. Only a few papers focused on quantitation in bi-
opsy samples, e.g., in renal biopsies from rats and humans for
the immunosuppressant drugs mycophenolic acid and tacroli-
mus. Tissue samples were homogenized either mechanically
or enzymatically and then underwent liquid-liquid extraction
(LLE). Sensitive instrumentation such as liquid chromatogra-
phy (LC) coupled to mass spectrometry (MS) is required as
only minimal sample amount of about 20mg/biopsy is usually
available [5, 6].
In postmortem toxicology, substances of different pharma-
cological classes such as opiates, benzodiazepines, antidepres-
sants, neuroleptics, or drugs of abuse are of interest with often
limited knowledge on consumed drugs prior to analysis. As
ideal sample preparation and analytical instrumentation may
vary between matrices and substance classes, often different
analytical methods are used for quantitation [7]. However,
sufficient sample amount is necessary which is often difficult
for postmortem samples especially with biopsy samples.
Multi-analyte procedures aiming at covering a multitude of
relevant compounds seems to represent an interesting alterna-
tive. Unspecific extraction methods such as protein precipita-
tion (PP) allow simultaneous extraction of various substance
classes and are fast and cheap. However, extract purity after
PP is low especially with postmortem matrices and tissue ex-
tractions which in turn can lead to severe matrix effects [8].
These problems are reduced using more sophisticated LLE or
solid-phase extractions (SPE) [9]. On the other hand, LLE and
SPE are more specific and may not work for simultaneous
extraction of various substance classes. Several methods cov-
ering a large amount of analytes have been published in recent
years and are summarized in [10].
Another major challenge in quantifying that many com-
pounds with different therapeutic and/or toxic concentration
ranges in different matrices in only one analytical run is to find
calibration models which can handle the huge dynamic range
without source or detector saturation of the MS. Different
strategies to overcome these problems have been applied in-
cluding the use of offset voltage parameters, less-sensitive
product ions, polarity switching, or 13C product ions [11,
12]. The naturally occurring 13C isotope is usually about
1.1 % of all carbon atoms producing a much lower MS signal
compared with 12C. Using the 13C isotope as precursor ion can
help avoid saturation effects. The 13C isotope is stable, and its
distribution underlies geological differences [13]. To the best
of our knowledge, only Bergeron et al. tested the use of a 13C
isotope as precursor for the simultaneous quantitation of
mebeverine and its metabolite as both show large differences
in their therapeutic plasma concentration ranges. However, in
their case, application of 13C precursors did not give the de-
sired result and the strategy of polarity switching was used
instead for final quantitation [11].
Although forensic toxicologists are aware of the PMR ef-
fect, it is still under-explored. Especially systematic studies on
time-dependent postmortem changes are limited and are diffi-
cult to conduct due to practical and even more important due
to ethical reasons. To provide better insight into time-
dependent PMR processes in blood as well as in different
postmortem tissues, a novel, sensitive method should be de-
veloped and validated using LC-MS/MS allowing simulta-
neous quantitation in low amount of biopsy samples of differ-
ent postmortem tissues for a multitude of over 80 forensically
relevant compounds. This method should create the prerequi-
sites for further studies on time-dependent PMR.
Materials and methods
Chemicals and reagents
Methanolic or acetonitrilic solutions (1 mg/mL) of 6-
monoacetylmorphine (MAM), agomelatine, alprazolam,
amisulpride, amitriptyline, amphetamine, nortriptyline,
aripiprazole, benzoylecgonine (BEC), bromazepam,
bupropion , hydroxybupropion (OH-bupropion) ,
chlorprothixene, clonazepam, 7-aminoclonazepam,
citalopram, clomipramine, norclomipramine, clozapine,
norclozapine, cocaine, codeine, diazepam, dihydrocodeine
(DHC), doxepine, nordoxepine, duloxetine, ecgonine methyl
ester (EME), fentanyl, fluoxetine, norfluoxetine, flupentixol,
flunitrazepam, 7-aminoflunitrazepam, flurazepam, N-
desalkylflurazepam, hydroxyethylflurazepam (OH-
flurazepam), haloperidol, hydrocodone (HC), hydromorphone
(HM), imipramine, ketamine, levomepromazine, lorazepam,
meta-chlorophenylpiperazine (mCPP), methadone, 1,5-di-
methyl-3,3-diphenylpyrrolidine (EDDP), methamphetamine,
3 , 4 -me thy l ened ioxyamphe t amine (MDA) , 3 ,4 -
methylenedioxy-N-ethylamphetamine (MDEA), 3,4-
methylendioxymethamphetamine (MDMA), methylpheni-
date (MPH), midazolam, α-hydroxymidazolam (OH-midazo-
lam), mirtazapine, morphine, nitrazepam, nordazepam,
olanzapine, opipramol, oxazepam, oxycodone, oxymorphone,
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paroxetine, perazine, pethidine, pipamperone, promazine,
quetiapine, risperidone, 9-hydroxyrisperidone (OH-risperi-
done), sertraline, trazodone, temazepam, tramadol, O-
desmethyltramadol (ODMT), triazolam, trimipramine,
venlafaxine, O-desmethylvenlafaxine (ODMV), zolpidem
and zopiclone and methanolic solutions of the deuterated in-
ternal standards (IS; 0.1 mg/mL), MAM-d3, alprazolam-d5,
amisulpride-d5, amitriptyline-d3, amphetamine-d6,
aripiprazole-d8, citalopram-d6, clomipramine-d3, clonaze-
pam-d4, 7-aminoclonazepam-d4, clozapine-d3, cocaine-d3,
BEC-d3, EME-d3, codeine-d3, diazepam-d5, duloxetine-d3,
fentanyl-d5, flunitrazepam-d3, 7-aminoflunitrazepam-d3, flu-
oxetine-d6, norfluoxetine-d6, N-desalkylflurazepam-d4,
flurazepam-OH-d4, haloperidol-d4, ketamine-d4, lorazepam-
d4, mCPP-d8, MDMA-d5, methadone-d9, methamphet-
amine-d9, methylphenidate-d9, midazolam-d4, midazo-
lam-OH-d4, morphine-d3, nordazepam-d5, oxazepam-
d5, paroxetine-d6, pethidine-d4, pipamperone-d10,
quetiapine-d8, risperidone-d4, temazepam-d5, tramadol-
d3, trazodone-d6, triazolam-d4, trimipramine-d3,
venlafaxine-d6, zolpidem-d6 and zopiclone-d4 were ob-
tained from AdipoGen (Liestal, Switzerland), Lipomed
(Arlesheim, Switzerland), LGC (Wesel, Germany), or
Ceril l iant (del ivered by Sigma-Aldrich, Buchs,
Switzerland). Water was purified with a Purelab Ultra
Mil l ipore f i l t ra t ion uni t (Labtech, Vil lmergen,
Switzerland) and acetonitrile of HPLC grade was ob-
tained from Fluka (Buchs, Switzerland). All other
chemicals used were from Merck (Zug, Switzerland)
and of the highest grade available.
Biosamples
Human blank whole blood samples from the femoral veins
(femoral blood (FB)) and the heart (heart blood (HB)), cere-
brospinal fluid (CSF) from the lumbar spine, urine, muscle,
liver, kidney, lung, spleen, brain tissue, and adipose tissue
(AT) were used for method development and validation.
They were obtained from postmortem cases that were
submitted to the authors’ laboratory and autopsied by
order of the state attorney. Ethical approval was obtain-
ed by the Cantonal Ethics Committee of Zurich (ap-
proval number 42.2005).
Sample preparation
Body fluid and tissue samples were extracted by a two-step
LLE; 20 mg body tissue (muscle, liver, kidney, lung, spleen,
adipose, or brain tissue) were weighed into 2 mL plastic tubes
containing metal beads and homogenized using a Fast Prep®-
24 Instrument (MP Biomedicals, Illkirch, France). Twenty
microliters of body fluid (blood, CSF, or urine) were extracted
in a 2-mL Eppendorf tube (Schoenenbuch, Switzerland). To
each sample (homogenized tissues or body fluids), 50 μL IS
mixture (concentrations are given in the Electronic supple-
mentary material (ESM) Table S1) and 10 μL spiking solution
were added. The first LLE was performed by adding 250 μL
of 0.2 M phosphate buffer (pH 7.4) and 0.8 mL of butyl
acetate/ethyl acetate (BuAc/EtAc; 1:1, v/v). The mixture was
shaken for 10 min and centrifuged (5 min, 10,000 rpm), and
750 μL supernatant were transferred into an autosampler vial.
To the remaining sample, 100 μL of 0.1 M NaOH was added
(pH 13.5) and the second LLE was performed by adding an-
other 0.8 mL of BuAc/EtAc (1:1, v/v), shaking, and centrifu-
gation as described above. Eight hundred microliters of super-
natant was added to the first extract, and after addition of
25 μL formic acid (20 %, v/v), evaporated to dryness under
a gentle stream of nitrogen at 40 °C. The sample was
reconstituted in 60 μL mobile phase (eluent A/B 90:10
(v/v), see below) and analyzed by LC-MS/MS.
LC-MS/MS settings
The analysis was performed using a Thermo Fisher Ultimate
3000 UHPLC system (Thermo Fisher, San Jose, California,
USA) coupled to an Sciex 5500 QTrap linear ion-trap quad-
rupole mass spectrometer (Sciex, Darmstadt/Germany). The
LC settings were as follows: Phenomenex (Aschaffenburg,
Germany) Synergy Polar RP column (100×2.0 mm,
2.5 μm), gradient elution with 10 mM ammonium formate
buffer in water containing 0.1 % (v/v) formic acid (pH 3.5,
eluent A), and acetonitrile containing 0.1 % (v/v) formic acid
(eluent B). Start conditions were 10% B for 1 min with a flow
rate of 0.5 mL/min, 1–10 min to 25 % B and 0.6 mL/min, 10–
17min concave upward to 95%B, hold at 95%B for 0.5 min,
at 17.5–18.5 min re-equilibrating to 10 % B and 0.5 mL/min.
Injection volume was 10 μL.
The Turbo V ion source equipped with a stainless steel
electrode (100 μm internal diameter) was operated in positive
electrospray ionization (ESI) mode with the following MS
conditions: gas 1, nitrogen (50 psi); gas 2, nitrogen (60 psi);
ion spray voltage, 5500 V; ion-source temperature, 450 °C;
curtain gas, nitrogen (30 psi); and collision gas, medium. The
MS was operated in the advanced scheduled multiple reaction
monitoring (MRM) mode using three transitions for each an-
alyte. The third transition corresponded to the 13C isotope of
the first transition. The mass spectrometer settings for MRM 3
were identical to those of MRM 1, except the Q1 and Q3
masses were set 1 Da higher. For each analyte transition, an
intensity threshold was defined. For the ISs, 1MRM transition
was used. The MS settings for each analyte are given in ESM
Table S2. The MS was controlled by Analyst® 1.6.2 software
(Sciex, Darmstadt/Germany). Quantitation was performed
with MultiQuant® 2.1.1 software (Sciex, Darmstadt/
Germany).
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Method validation
Preparation of calibration samples
Methanolic or acetonitrilic solutions (1 mg/mL) for each ana-
lyte were used as stock solutions for calibration spiking solu-
tions. Working solutions (0.1 and 0.01 mg/mL) were prepared
by dilution from each stock solution in methanol or acetoni-
trile, depending on the solvent delivered in. For antidepres-
sants and neuroleptics (ADN), two spiking solutions in meth-
anol (d0-mix 1 ADN MeOH and d0-mix 2 ADNMeOH) and
two spiking solutions in acetonitrile (d0-mix 1 ADNACN and
d0-mix 2 ADN ACN) for calibration standards were prepared
by mixing appropriate amounts of the corresponding stock or
working solutions as described previously [14]. For all other
analytes, two spiking solutions in methanol (d0-mix 1 rest
MeOH and d0-mix 2 rest MeOH) were prepared.
Different amounts of the d0-mixes 1 or 2 were diluted to a
total volume of 5 mL methanol or acetonitrile to give the final
calibration spiking solutions (Cal 1-13 ADN in methanol and
Cal 1-13 ADN in acetonitrile and Cal 1-13 rest in methanol) in
a final concentration two times higher than the aimed target
blood or tissue concentration.
The final calibration samples were prepared without ma-
trix; 10 μL of each calibration spiking solution was mixed
with IS and 25 μL formic acid (20 %, v/v) in an autosampler
vial, dried at 40 °C under nitrogen and reconstituted in 60 μL
eluent A and B (90:10, v/v). The final calibration ranges are
given in ESM Table S3 for each analyte.
Preparation of quality control samples
Stock, working, and spiking solutions were prepared as de-
scribed above from different stock solutions. Different
amounts of either methanolic or acetonitrilic stock or working
solutions were mixed to the quality control (QC) spiking so-
lution (low, med, high, 13C in methanol or acetonitrile), in a
final concentration two times higher than the corresponding
blood/tissue concentrations. The concentration of QC lowwas
defined between calibrators 1 and 2, QC med between cali-
brators 5 and 6, QC high between calibrators 9 and 10, and QC
13C between calibrators 12 and 13. QC samples were prepared
from 20 μL analyte-free body fluid or 20 mg analyte-free
body tissue and 10μL of the corresponding fortifying solution
in methanol and 10 μL of the corresponding fortifying solu-
tion in acetonitrile. The final QC concentrations are given in
ESM Table S3 for each analyte.
Selectivity and crosstalk
Five blank matrix samples from different sources were ana-
lyzed for peaks interfering with the detection of analytes or IS
for FB, HB, CSF, urine, muscle, liver, kidney, lung, spleen,
brain, and AT. A methanolic solution of the IS mixture was
analyzed to check for appropriate IS purity and presence of
native analytes. A methanolic solution of each analyte was
injected separately at concentrations of 1 or 10 μg/mL and
checked for interfering peaks. Analytes which showed inter-
fering peaks were then tested at their QC high and QC 13C
concentration.
Calibration model
Calibrators 1–13 were divided into two partly overlapping
calibrations, conventional 12C calibration with calibrators 1–
10 and isotope (13C) calibration with calibrators 8–13. In the
12C calibration, MRM 1 (12C isotope) was used as quantifier;
in the 13C calibration, MRM 3 (13C isotope of MRM 1) was
used as quantifier.
Calibration curves (single measurement per level at four
validation days) were prepared with each batch of validation
samples. The regression lines for both calibrations 12C and
13C were calculated using a simple linear model with 1/x
weighting. Requirements were back-calculated calibrator con-
centration of ±30 % of target and sufficient accuracy (±30 %
as described below for bias and precision) of the analyzed QC
samples. Only for analytes that did not fulfill these criteria,
additionally linear 1/x2, quadratic or semi-logarithmic qua-
dratic weighted 1/x, and 1/x2 least-square regression model
were tested. From those, a final calibration model was chosen,
which yielded the lowest bias and precision data over the four
validation days.
Matrix effects and extraction efficiency
FB, HB, CSF, urine, muscle, liver, kidney, lung, spleen, AT,
and brain tissue from five different postmortem cases were
used for the matrix-effect (ME) and extraction-efficiency
(EE) experiments at QC med concentration. The experi-
ments were performed according to Matuszewski et al.
[15]. Briefly, three sets of samples (X, Y, Z) were pre-
pared. Group X was spiked with IS and QC med spik-
ing solution before extraction, while group Y was
spiked after extraction. Group Z consisted of five QC
med samples without matrix. EE and ME were calculat-









Where X=analyte peak area in group X; Y=analyte peak
area in group Y; and Z=analyte peak area in group Z.
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Accuracy and precision
QC samples (low, high, 13C) were analyzed according to the
procedures described above in duplicates on each of 4 days.
Bias was calculated as the percent deviation of the mean cal-
culated concentration at each concentration level from the
corresponding theoretical concentration. Intra-day (RSDR)
and inter-day (RSDT) precisions were calculated as relative
standard deviation (RSD) according to [16].
Limits
The lower limits of quantitation (LOQ) were defined as the
concentrations of the first calibrator fulfilling the criteria of
signal to noise 1:10 determined via peak heights. The limits
of detection (LOD) were not systematically investigated.
Comparison of accuracy between 12C and 13C calibration
QC low was only calculated using 12C calibration, QC 13C
was only calculated using 13C calibration. QC high accuracy
was calculated in both calibrations and was compared by
Bland-Altman plots. For that, the average concentration of
QC high calculated via 12C and 13C calibration over 4 days
(see BAccuracy and precision^) was plotted versus the differ-
ence percentage between 12C and 13C calibrations.
Results and discussion
Although forensic toxicologists are aware of the PMR effect,
it is still under-explored. To provide better insight into time-
dependent PMR processes in blood and especially in different
postmortem tissues, biopsy samples should be collected at
admission of the corpse at the mortuary and again during
autopsy and compared for a novel study. Reliable conclusion
of results can only be drawn if the applied analytical method-
ologies can be shown to be precise enough to be able to ad-
dress concentration changes as actual postmortem changes
compared with analytical precision. Therefore, the aim of
the present study was the development and validation of a
rather simple and applicable LC-MS/MS method in 11 differ-
ent postmortem specimens, with special focus on acceptable
intra-day precision.
Sample preparation
Collection of solid tissue samples at more than one time point
without opening of the corpse is only possible using biopsy
sampling. Quantitation of drugs in postmortem biopsies has
not been published in the field of forensic toxicology yet.
Generally, only few publications exist about quantitation of
small molecules in tissue biopsies. In these studies, not only
was sample preparation started with mechanical homogeniza-
tion in most of the cases [6, 17] but also enzymatic and chem-
ical digestion was described [5, 18]. As digestion techniques
were rather time consuming and may lead to stability prob-
lems for some analytes, mechanical homogenization was cho-
sen for the present study. Due to small sample sizes of maxi-
mum 20 mg body tissue collected during biopsy or 20 μL
body fluid, only one extract could be generated from one
sample. Therefore, a rather unspecific sample preparation
was required allowing simultaneous extraction of a large num-
ber of analytes. In forensic toxicology, sample preparation of
postmortem matrices consists either of a PP, LLE, or SPE step
in most of the cases [19–21]. LLE or SPE are more time
consuming compared with the faster and rather unspecific
PP but can reduce ME more efficiently [9, 22]. Therefore, a
compromise had to be found allowing simultaneous extraction
of a multitude of forensically relevant compounds with a high
variety in physical-chemical properties but with still accept-
able ME in postmortem matrices. In preliminary experiments,
PP and different SPE and LLE procedures were compared in
terms of EE and ME (data not shown). LLE with BuAc/EtAc
(1:1, v v) at physiological and alkaline pH turned out to be the
best compromise. Due to the high sensitivity of the 5500
QTrap instrument, 20 mg of body tissue or 20 μL of body
fluid were sufficient to quantitate low therapeutic concentra-
tions for the majority of the analytes even if LLE was not the
optimal extraction procedure as, e.g., for morphine.
Calibration optimization
Usually, it is recommended to perform calibration in the ma-
trix type of the analyzed sample. Due to the high number of
investigated matrices in one case and the fact that blank post-
mortem tissue samples are difficult to obtain in sufficient
quantity, it was impossible to generate calibration curves for
all 11 matrices. For practical reasons, a simple solvent calibra-
tionwas chosen for all matrices. It has to bementioned that the
major focus of the presented method should be the precise
comparison between different time points in one sample ma-
trix instead of high accuracy between different matrices.
Therefore, although being aware of the fact that a solvent
calibration may lead to accuracy problems, it was a reasonable
approach to compare concentration changes within one type
of matrix.
Another major challenge in quantifying so many com-
pounds with different therapeutic and/or toxic concentration
ranges in different matrices in only one analytical run is to find
calibration models which can handle the huge dynamic range
without source or detector saturation of the MS. Some neuro-
leptics such as flupentixol have therapeutic blood concentra-
tion ranges in the low microgram-per-liter range while, e.g.,
trazodone has therapeutic blood levels up to 2500 μg/L.
Starting the analysis, it is usually unknown whether
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therapeutic or even toxic levels several times higher than ex-
pected from recommended therapeutic blood concentrations
are present. Furthermore, large concentration differences can
occur between the different matrices. CSF contained mostly
very low concentrations, whereas, e.g., liver and lung usually
contained concentrations up to 100 to 200 times higher than
those in the blood [2, 20, 23]. As biopsy samples could be
analyzed only once, the calibration range had to cover an
extreme dynamic range. Trying to calibrate in such a wide
range led toMS saturation problems. In a first step, alternative
MRM transitions with lower intensities were chosen as quan-
tifiers. Additionally, the declustering potentials were modified
to be in a less optimal range, to further lower the signal inten-
sities. However, although the use of alternative MRM transi-
tions and modification of the declustering potentials lead to
less saturation in higher concentrations, low therapeutic con-
centrations could not be analyzed anymore. In a second ap-
proach, a third MRM transition was introduced corresponding
to the 13C isotope of MRM 1. As 13C makes up only about
1.1 % of natural carbon, this signal was expected to be less
intense and less prone to saturation allowing a linear calibra-
tion even in highest concentrations. As exemplarily shown for
risperidone in Fig. 1, the sole use of 12C calibration showed
strong saturation effects at higher concentrations (A), while
dividing the whole calibration range in MRM 1 (12C) for
lower (B) and MRM 3 (13C) for higher concentrations (C)
resulted in linear calibration models over the whole respective
range. In mass spectrometry, 13C isotopes have various appli-
cations. They are used to label target molecules for example in
metabolomics or proteomics [24] or are used to produce la-
beled internal standards [25]. Naturally and unnaturally occur-
ring 12C/13C ratios are determined in environmental, food,
medicinal, or forensic chemistry using isotope ratio mass
spectrometry [26]. The general validity of this calibration ap-
proach was further investigated and proven during the final
validation process as described below.
LC-MS/MS optimization
The final MRM chromatogram of the 83 analytes (MRM 1) is
given in Fig. 2. The presence of the 83 analytes was success-
fully screened for by mass spectrometry with selected MRM
for each analyte using two MRM transitions for 12C and an
additional MRM 3 for 13C. Only norfluoxetine showed only
one fragment in MRM 1 and 3. Generally, guidelines recom-
mend the use of two qualifying ion fragments in addition to
the quantifier. In the presented method, MRM 3 was exclu-
sively a quantifier. The addition of another qualifier ion would
have led to increased cycle times and consequently to a loss of
data points. In real cases, analyte identity is already confirmed
prior to quantitation, as heart blood is screened using a differ-
ent LC-MS/MS screening method including enhanced prod-
uct ion scans and comparison of the mass spectra with an in-
house library. Therefore, monitoring of one qualifier should be
sufficient in the quantitation method. Even monitoring of over
80 compounds with three MRM transitions each was only
possible using a new, advanced scheduled MRM mode in
Analyst® 1.6.2 software. After introducing a certain intensity
threshold for each analyte, MRM 2 and 3 were only measured
as long as MRM 1 stayed above the defined intensity thresh-
old. Additionally, the scheduled MRM windows were
narrowed for the later part of the chromatogram where many
analytes were co-eluting. Combining intensity thresholds for
each analyte and variable scheduled MRM windows, a mini-
mum of 8 to 10 data points per peak was achieved for the
majority of the analytes. As expected, baseline separation of
over 80 analytes is impossible within reasonable runtimes.
Especially in the last 2 min, several analytes are still co-
eluting but could be sufficiently differentiated by mass spec-
trometry with exception of fluoxetine/methadone and 13C-clo-
mipramine/chlorprothixene. Some analyte pairs like codeine-
d3 / 1 3C-d i hyd rocode i n e and ven l a f ax i n e - d6 / 7 -
aminoflunitrazepam were overlapping only at high
concentrations.
Besides interference in MRM transitions possibly leading
to wrong identification, co-elution of two or more compounds
might result in ion suppression or ion enhancement between
various analytes, especially when using ESI. Such effects,
when present in the analyte mixture of calibration samples,
but not in authentic samples would result in falsely increased
or decreased quantitation results [27]. However, as compari-
son of analyte concentrations at different time points in the
very same case would still be possible in a relativemanner, ion
suppression and enhancement of co-eluting analytes should
play a minor role and was therefore not further investigated.
Method validation
Validation was performed based on national and international
guidelines [16, 28] with some modifications as described in
the respective sections. Validation of a huge number of 83
analytes in 11 different matrices required these modifications
and since special focus for a future PMR study was on an
acceptable intra-day precision, some enlargements of accep-
tance limits for other parameters were acceptable. Even then,
it is clear that criteria could not be met for all analytes in every
respective matrix. Still, overall results of validation were sur-
prisingly good.
Selectivity and crosstalk
No interfering peaks were detected in the blank matrices of
FB, HB, and CSF. Peaks at the retention time of diazepam
(MRM 1–3), EME (MRM 1), MPH (MRM 1), tramadol
(MRM 1), and venlafaxine (MRM 1) were detected in some
of the blank tissue matrices but in negligible amounts below
8686 S.N. Staeheli et al.
Fig. 1 Risperidone calibration
over the whole concentration
range showing strong saturation
effects in higher concentrations
(a). Division of the total
calibration curve in MRM 1 (12C)
for lower (b) and MRM 3 (13C)
for higher concentrations (c)
resulted in linear calibration
models over the whole
concentration range. QC low was
only calculated using 12C
calibration, QC 13C only using
13C calibration. QC high could be
calculated with both calibrations
Fig. 2 LC-MS/MS chromatogram of the 83 analytes (MRM 1)
Dynamic range extended LC-MS/MS method for PMR studies 8687
the lowest calibrator. The IS mixture showed small peaks for
clomipramine, norclomipramine, EDDP, HC, MPH,
mirtazapine and pethidine, which all had areas far below cal-
ibrator 1. However, it has to be mentioned, that all matrices
used for this experiment were from authentic cases and had
been assigned as Bblank^ samples based on a routinely per-
formed blood/urine screening. Very low concentrations of
some analytes irrelevant for the particular case might have
been present and might be the reason for the observed
interferences.
Due to the extremely broad calibration range, injection of
some analytes at their QC 13C concentrations lead to peak
broadening and deterioration of separation from adjacent
compounds. For example, DHC and morphine influenced co-
deine-d3, oxymorphone, and HM. However, the interference
peak area of codeine-d3 made up only 2 % of its regular IS
area and was therefore considered as irrelevant.
Oxymorphone and HMwere only partly influenced and there-
fore insignificant for routine analysis. 7-aminoflunitrazepam
was not baseline separated from venlafaxine-d6 anymore, but
comparing the IS areas of the low and high calibrators, the
area of venlafaxine-d6 was not influenced to a significant
extent. Clomipramine lead to interfering peaks with the quan-
tifier and qualifier of chlorprothixene and norclomipramine at
a concentration between calibrators 2 and 3. Injection of clo-
mipramine at its QC high concentration did show the same
effect, but concentrations were below the lowest calibrator. On
the other hand, chlorprothixene or norclomipramine did not
influence clomipramine. As the interferences only appeared in
the highest calibrators and the resulting change in peak areas
was only small, the accuracy of the calibrators should not be
affected to a relevant extent. Problems would arise, if a sample
contained high clomipramine concentrations together with
low chlorprothixene or norclomipramine concentrations. In
such a case, the chlorprothixene and norclomipramine con-
centrations would have to be interpreted with caution or a
separate calibration for each analyte had been necessary.
Taking into consideration that such a combination of analytes
should be very seldom, results for selectivity and crosstalk
were vastly satisfying and in addition, crosstalk was not ob-
served for all other compounds, even in the highest concen-
trations tested.
Calibration model
If possible, the simplest linear regression model with 1/x or
1/x2 weighting was used. Only analytes that did not fulfill the
required criteria using linear regression models were addition-
ally tested for quadratic regression models. The final regres-
sion models, weighting factors, and the respective ISs are
given in ESM Table S3. QC low was only calculated using
12C calibration, while QC 13C was only calculated using 13C
calibration. QC high accuracy was calculated using both
calibrations. From the 83 analytes, in the 12C calibration only
ten analytes and in the 13C calibration only five analytes did
not fulfill the criteria for linear calibration and were therefore
fitted to a second-order model to finally meet the criteria. In
total, five analytes did not fulfill a back-calculated calibrator
concentration of ±30 % in the 12C calibration and the 13C
calibration in all regression models, what may have been
caused by the lack of an appropriate IS.
Matrix effects and extraction efficiency
Based on international validation guidelines, EE andME stud-
ies are usually performed at two concentration levels, low and
high [16, 28]. Due to the high number of analytes and different
postmortem matrices, the ME and EE experiments were only
performed at QC med. ME data and RSD of all analytes in all
matrices are summarized in ESM Table S4. Briefly, an ion
suppression greater than 25 % in all matrices was observed
for EME, norfluoxetine, flupentixol, hydromorphone,
oxymorphone, and sertraline, while agomelatine, amitripty-
line, nortryptiline, aripiprazole, chlorprothixene, clomipra-
mine, norclomipramine, clonazepam, norclozapine, diaze-
pam, nordazepam, duloxetine, flunitrazepam, fluoxetine,
desalkylflurazepam, haloperidol, nitrazepam, paroxetine, and
trimipramine exhibited ion suppression only in tissues but not
in liquid matrices. Thirty-eight analytes (46 %) were affected
by ion suppression exclusively in brain and/or AT. Overall,
matrices did not cause ion suppression or enhancement in the
same extent. Ion suppression could be observed for only 6
analytes in CSF, for 8 analytes each in FB and HB, and for
12 analytes in urine. CSF was therefore the matrix causing the
least ME, followed by blood and urine. Muscle, lung, spleen,
and kidney were similarly affected with 22 to 27 suppressed
analytes. Worse results could be observed in liver with 36
suppressed analytes and brain and AT with 74 and 80 sup-
pressed analytes, respectively. Brain and AT are the matrices
with the highest lipid content, which might be the cause of the
extensive ion suppression. The fact that the body fluids
showed less ME compared with the solid tissues supports
the assumption that lipophilic matrix components are the main
cause of ion suppression [29, 30]. Additionally, many
analytes which only elute at a higher organic solvent
percentage (RT >13 min; where lipophilic matrix is
known to elute) were affected by ion suppression in
the solid tissues. The ME of EME, morphine, oxymorphone,
HM, and amphetamine may be explained by the early elution
at an RT less than 2 min that probably falls together with salts
from the matrices. In these cases, body fluids and solid tissues
were affected to the same extent. Ion enhancement greater
than 25 % was observed for 7-aminoclonazepam, 7-
aminoflunitrazepam, OH-flurazepam, levomepromazine,
olanzapine, perazine, pipamperone, promazine, risperidone,
and temazepam in different matrices (ESM Table S4).
8688 S.N. Staeheli et al.
Olanzapine is known to be unstable and susceptible to oxida-
tion in biological matrices [31, 32]. Levomepromazine,
perazine, promazine, and promethazine are phenothiazines
known to be easily oxidized to sulfoxides [33]. This could
be the reason, why these compounds did not pass the specifi-
cations. The thioxanthenes chlorprothixene and flupentixol
are structurally related to the phenothiazines and might also
be affected by oxidation. Interestingly, thioxanthenes were
prone to strong ion suppression in contrast to phenothiazines,
which suffered from strong ion enhancement. As the
thioxanthenes eluted closely together at high retention times,
the ion suppression may have been caused by lipophilic ma-
trix components such as fatty acids. As it was expected from
postmortem tissues, many compounds exhibited ion suppres-
sion or enhancement, but for most analytes these effects were
reproducible (RSD <15 %) and therefore tolerable, as long as
the method was sensitive enough. As given in ESM Table S4,
only four analytes in body fluids, eight analytes in muscle, and
only one analyte in AT did not pass these criteria. In contrast,
23 to 45 analytes in spleen, lung, kidney, liver, and brain were
outside these criteria. Use of an IS—usually applied in routine
analysis—could further compensate these deviations in all
matrices as shown in summary for all analytes and tissues in
Table 1. Briefly, in body fluids only olanzapine was still above
the set criteria of 15 % and in body tissues only bupropion,
flupentixol, EDDP, olanzapine, opipramol, oxymorphone,
perazine, sertraline, ODMT, and ODMV still exceeded the
criteria. The mentioned analytes that did not benefit from IS
compensation, were analytes without an appropriate IS with
comparable structure or RT.
Determination of EE was done comparing blank tissue ma-
trix spiked before and after extraction. Of course, this may not
reflect the true recovery of substances from authentic tissue
samples, where the substances may not be dissolved to the
same extent as after spiking them onto the matrix. However,
recovery from authentic samples could not be determined for
over 80 analytes in several tissues due to unavailability of
sufficient reference material and for practical reasons.
Therefore, the approach in the present experiment seemed to
be the most appropriate. A summary of the EE for all analytes
in all matrices is given in ESM Table S5. Generally, EE was
between 70 and 90 % for the majority of the analytes in the
different matrices. EE below 50 % in all matrices was only
observed for BEC andmorphine. In blood, CSF, urine, kidney,
muscle, lung, and AT, 3 to 10 analytes, and in liver, brain, and
spleen, 16 to 24 analytes had EEs below 50 %. Especially,
considering the fact that a solvent calibration was used, low
EE from matrix should result in bad accuracy. However, as
already described for ME, usage of IS may have been com-
pensated for bad EE as shown in ESM Table S6. With IS
compensation, only nortryptiline, bupropione, norclozapine,
flupentixol, levomepromazine, EDDP, nitrazepam,
olanzapine, opipramol, oxymorphone, perazine, promazine,
promethazine, and sertraline had recoveries below 80 %.
Standard deviation above 15 % indicating unreproducible
EE in more than one matrix was only seen for nortryptiline,
bromazepam, bupropion, norclozapine, nordoxepine,
flupentixol, OH-flurazepam, HC, HM, levomepromazine,
mCPP, EDDP, olanzapine, opipramol, oxymorphone,
perazine, promazine, promethazine, sertraline, ODMT, and
ODMV. Overall, ME and EE were comparable with typical
multi-analyte methods.
Accuracy and precision
In forensic toxicology, national and international guidelines
exist, which recommend various validation procedures [16,
28]. If these full validation recommendations exceed the pos-
sibilities of a laboratory in terms of time and cost, simplified
partial validations can be performed [28]. Due to the high
number of matrices, accuracy and precision experiments were
performed in a modified validation procedure generating data
over 4 instead of 8 days. FB and HB were handled as one
matrix named blood in general for accuracy and precision
experiments. Results of the accuracy and precision experi-
ments are given in Table 2. As the aim of the future study is
to assess concentration differences between 2 and 3 time
points—intra-day precision was considered the most impor-
tant point to focus on in the method validation process.
Therefore, bias, intra-day, and inter-day precision will be
discussed separately in the following.
As a solvent calibration was used, bias was expected to
some extent, e.g., for those analytes with low recoveries and/
or not having an appropriate IS. However, even if the accuracy
did not fulfill the acceptance criteria, concentration differences
can still be assessed relatively. Nevertheless, 38 analytes ful-
filled the criteria of ±30 % in all matrices. The best results
were obtained in body fluids, with 75–81 % of the analytes
passing the accuracy requirements. The body tissues compar-
atively caused bias in more analytes with only 66–71 % of the
analytes passing the criteria. Compounds with bad accuracy
results (detected in more than two matrices) were
nortryptiline, bupropion, OH-bupropion, chlorprothixene,
clomipramine, norclozapine, cocaine, BEC, EME, codeine,
DHC, nordoxepine, flupentixol, haloperidol, HC, HM,
levomepromazine, mCPP, MDEA, EDDP, MPH, morphine,
olanzapine, oxycodone, oxymorphone, perazine,
pipamperone, promazine, promethazine, quetiapine, sertra-
line, ODMT, and ODMV. Out of the 51 analytes with an
appropriate deuterated IS, 78 % showed good accuracy re-
sults. Of the 32 analytes without appropriate IS, only 22 %
had acceptable accuracy results.
The intra-day precision criteria were fulfilled by the major-
ity of the analytes (Table 2). There was no apparent difference
in precision between the matrices observed. In all matrices,
83–93 % of the analytes had an intra-day precision below


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8708 S.N. Staeheli et al.
20 % for all QC samples, with exception of brain where only
75 % of the analytes passed the criteria. As not always the
same analytes failed, only 49 analytes (59 %) passed the
criteria of the intra-day experiment in all ten matrices.
Analytes failing in more than two matrices were bupropion,
chlorprothixene, norclomipramine, flupentixol, flurazepam,
HC, levomepromazine, mCPP, EDDP, olanzapine, opipramol,
perazine, pipamperone, promazine, promethazine, sertraline,
and ODMV. All those analytes except mCPP and
pipamperone did not have an IS with similar structure or re-
tention time. In case of mCPP and pipamperone, the RTs of
the IS mCPP-d8 and pipamperone-d10 shifted due to the rath-
er high deuteration grade, which might have been responsible
for the insufficient compensation. PMR for substances with
low precision in a certain matrix will have to be interpreted
with care—if reasonable interpretation will be possible at
all—considering high analytical variations.
The inter-day precision seemed to be more matrix depen-
dent than intra-day precision. In liver, brain, and AT, 60–64 %
of the analytes showed a precision below 20 %. In the other
matrices, 76–83% of the analytes passed the criteria (Table 2).
Also in this experiment, the intersection was smaller with only
43 % of the analytes passing the criteria in all ten matrices.
Additionally to the above-mentioned analytes, nortryptiline,
OH-bupropion, clomipramine, norclozapine, nordoxepine,
OH-f lu razepam, lo razepam, MDA, n i t r azepam,
oxymorphone, quetiapine, ODMT, and trazodone failed the
criteria in more than two matrices. Again, mainly analytes
with no appropriate IS were affected.
In summary, all accuracy and precision parameters were
fulfilled for 51 compounds in blood, 59 analytes in urine, 58
in CSF, 54 in muscle, 52 in kidney and spleen, 43 in liver, 42
in AT, and 41 in brain tissue. Twenty-eight analytes fulfilled
all parameters in all ten matrices. Taking into consideration
that so many analytes had been assessed in so many different
matrices using a calibration in solvent instead of matrix and a
calibration extension by 13C isotopes, the overall performance
in terms of accuracy and precision was perfectly acceptable.
Limits
The LOQs are listed in ESM Table S3. Although sample
amount was a lot smaller compared with other quantitation
methods used in forensic toxicology, LODs were in a compa-
rable range [14, 34]. As the detection of lower analyte con-
centrations was not of interest for the future application of the
method, determination of LOD was resigned.
Comparison of 12C and 13C calibrations
In order to achieve a sufficient dynamic calibration range, two
calibrations were combined: first, a conventional calibration
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second, an additional isotope calibration with a MRM 3 (13C)
for higher concentrations (Fig. 1). Applicability of this ap-
proach was tested by comparing accuracy of QC high deter-
mined using both calibrations. As exemplified for four matrices
in Fig. 3, a difference in the calculated concentrations of QC
high between the conventional and the isotope calibration great-
er than 20 % was observed for five to seven analytes in each
matrix. From the mentioned exceptions, levomepromazine,
perazine, and promazine were above 20 % in all and clomipra-
mine, flupentixol, olanzapine, oxymorphone, and ODMV in
more than two matrices. Although it seems as if the same
analytes have similar errors in the different matrices (Fig. 3),
no systematic findings were observed. For example, ODMV
showed an error of −30 % in blood, −20 % in CSF, and +
25 % in liver but was within ±20 % in all other matrices.
Only levomepromazine, promazine, and oxymorphone showed
a deviation in a similar range, so that changes in the calibration
models might have improved the closeness between 12C and
13C calibrations. However, this might have worsened the bias
for QC low or 13C. Generally, these analytes also showed prob-
lems in the other validation experiments, whichmay explain the
deviations. Especially for these analytes, all samples of one case
should be calculated either within 12C or 13C calibration. In
general, combining 12C and 13C calibration successfully ex-
panded the dynamic range without observing saturation effects.
Conclusions
An LC-MS/MS multi-analyte method for the simultaneous
quantitation of 83 analytes in 11 postmortem matrices extract-
ed from low milligram biopsy samples and small volumes of
body fluids was developed with the aim to investigate concen-
tration changes in postmortem samples taken at different time
points. An extremely wide calibration range was achieved
using a combination of a conventional (12C) calibration for
low to moderate concentrations and a 13C isotope calibration
of the same MRM for high concentrations. Calibration was
successfully performed with external calibrators in solvent
without matrix. The method was validated in terms of selec-
tivity, crosstalk, ME, EE, accuracy, precision, and calibration
model. Intra-day precision was the most important point in the
validation process, considering the aim of concentration com-
parison between different time points in one matrix.
Fig. 3 Differences (%) of the average QC high concentration calculated with 12C calibration and 13C calibration is depicted as Bland-Altman Plot of all
analytes exemplarily in blood (a), muscle (b), CSF (c), and liver (d). Dotted lines represent deviation of ±20 %
8710 S.N. Staeheli et al.
Depending on the matrix, 75–93% of the analytes fulfilled the
criteria for a future study on time-dependent PMR, which is
surprisingly good for such a universal method.
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